| Dr Shelly Hartley, | |
|
1520 E Exchange Pkwy, Allen, TX 75002-4503 | |
| (214) 547-8671 | |
| (214) 547-9952 |
| Full Name | Dr Shelly Hartley |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1520 E Exchange Pkwy, Allen, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043816176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 41107 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shelly Hartley, 1523 Bethlehem Rd, Allen, TX 75002-5315 Ph: (971) 342-7144 | Dr Shelly Hartley, 1520 E Exchange Pkwy, Allen, TX 75002-4503 Ph: (214) 547-8671 |
News Archive
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests and remain free of cardiac events.
Cynthia Rogers, MD, visits a baby in the Newborn Intensive Care Unit at St. Louis Children's Hospital. Rogers is helping lead a national study aimed at understanding how prenatal factors and early life experiences influence brain development and behavior in infants and young children.
When the surgeon surgically removes a melanoma, some patients are said to be 'cancer-free' and they do not get additional treatment. However, should the fluid obtained in the drainage implanted after surgery be tested using the liquid biopsy technique rather than be disposed of as medical waste, the test might predict the high or low risk of cancer recurrence.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).
› Verified 7 days ago
James Randy Viator, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5205 Eastgate Ln, Allen, TX 75002 Phone: 972-442-0563 Fax: 860-754-0910 | |
Samreen Asif, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1997 Cousins Trl, Allen, TX 75013 Phone: 410-733-1052 | |
Paul M Mekaowulu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1504 Riverdale Dr, Allen, TX 75013 Phone: 214-383-6660 | |
Asten Floyd, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1819 E Bethany Dr, Allen, TX 75002 Phone: 972-359-2884 | |
Ms. Dana Dang Bui, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 510 E Main St, Allen, TX 75002 Phone: 972-727-6509 | |
Joel Gibson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 510 E Main St, Allen, TX 75002 Phone: 972-727-6509 |